Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs?

Kristina Busygina, Viola Denzinger, Isabell Bernlochner, Christian Weber, Reinhard Lorenz, Wolfgang Siess*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1212-1221
Number of pages10
JournalThrombosis and Haemostasis
Volume119
Issue number8
DOIs
Publication statusPublished - Aug 2019

Keywords

  • ACALABRUTINIB ACP-196
  • BRUTONS TYROSINE KINASE
  • Btk inhibitor
  • CA2+ ENTRY
  • COMPLEMENTARY ROLES
  • GLYCOPROTEIN-VI
  • GPIb
  • GPVI
  • GPVI-FC
  • PLATELET THROMBUS FORMATION
  • SRC FAMILY
  • TERM-FOLLOW-UP
  • X-LINKED AGAMMAGLOBULINEMIA
  • X-linked agammaglobulinemia
  • bleeding
  • platelet

Cite this

Busygina, K., Denzinger, V., Bernlochner, I., Weber, C., Lorenz, R., & Siess, W. (2019). Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs? Thrombosis and Haemostasis, 119(8), 1212-1221. https://doi.org/10.1055/s-0039-1687877
Busygina, Kristina ; Denzinger, Viola ; Bernlochner, Isabell ; Weber, Christian ; Lorenz, Reinhard ; Siess, Wolfgang. / Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs?. In: Thrombosis and Haemostasis. 2019 ; Vol. 119, No. 8. pp. 1212-1221.
@article{13352cac75cf4892b9961c7e5f2c817f,
title = "Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs?",
keywords = "ACALABRUTINIB ACP-196, BRUTONS TYROSINE KINASE, Btk inhibitor, CA2+ ENTRY, COMPLEMENTARY ROLES, GLYCOPROTEIN-VI, GPIb, GPVI, GPVI-FC, PLATELET THROMBUS FORMATION, SRC FAMILY, TERM-FOLLOW-UP, X-LINKED AGAMMAGLOBULINEMIA, X-linked agammaglobulinemia, bleeding, platelet",
author = "Kristina Busygina and Viola Denzinger and Isabell Bernlochner and Christian Weber and Reinhard Lorenz and Wolfgang Siess",
year = "2019",
month = "8",
doi = "10.1055/s-0039-1687877",
language = "English",
volume = "119",
pages = "1212--1221",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Georg Thieme Verlag",
number = "8",

}

Busygina, K, Denzinger, V, Bernlochner, I, Weber, C, Lorenz, R & Siess, W 2019, 'Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs?', Thrombosis and Haemostasis, vol. 119, no. 8, pp. 1212-1221. https://doi.org/10.1055/s-0039-1687877

Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs? / Busygina, Kristina; Denzinger, Viola; Bernlochner, Isabell; Weber, Christian; Lorenz, Reinhard; Siess, Wolfgang.

In: Thrombosis and Haemostasis, Vol. 119, No. 8, 08.2019, p. 1212-1221.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs?

AU - Busygina, Kristina

AU - Denzinger, Viola

AU - Bernlochner, Isabell

AU - Weber, Christian

AU - Lorenz, Reinhard

AU - Siess, Wolfgang

PY - 2019/8

Y1 - 2019/8

KW - ACALABRUTINIB ACP-196

KW - BRUTONS TYROSINE KINASE

KW - Btk inhibitor

KW - CA2+ ENTRY

KW - COMPLEMENTARY ROLES

KW - GLYCOPROTEIN-VI

KW - GPIb

KW - GPVI

KW - GPVI-FC

KW - PLATELET THROMBUS FORMATION

KW - SRC FAMILY

KW - TERM-FOLLOW-UP

KW - X-LINKED AGAMMAGLOBULINEMIA

KW - X-linked agammaglobulinemia

KW - bleeding

KW - platelet

U2 - 10.1055/s-0039-1687877

DO - 10.1055/s-0039-1687877

M3 - Article

VL - 119

SP - 1212

EP - 1221

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 8

ER -